Loading...
Loading...
The OMB is turning a Trump-era executive order into formal federal rules that would allow political appointees to override expert peer review and cancel grants anytime by citing a vague “national interest” standard. The proposal downgrades peer review, bans funding for certain cultural topics, limits international collaborations, and blocks spending on publishing and conference travel. Scientists, universities, and agencies like NIH, NSF, and DOE warn this could politicize research agendas, undermine U.S. competitiveness, and prompt legal challenges. The move centralizes control over grantmaking and risks disrupting longstanding peer-review processes and international scientific cooperation.
Tech leaders and researchers rely on predictable, expert-driven funding processes to plan projects, hire talent, and sustain collaborations. Centralizing grant authority and weakening peer review risks politicizing research priorities, disrupting programs, and increasing legal and operational uncertainty.
Dossier last updated: 2026-05-30 12:18:00
The Office of Management and Budget has proposed formal federal rules that would centralize grantmaking authority, reduce the role of peer review, and let political appointees cancel any federal research grant at any time if it’s not in the “national interest.” The rule would convert agency-specific guidance into binding regulations, restrict funding for certain topics, limit international collaborations, and block spending on activities like publishing and conference travel. Critics warn this shifts scientific funding decisions from expert reviewers to political actors, undermining the integrity and global competitiveness of U.S. research and risking legal challenges. The proposal advances administration priorities and would proceed through public comment before a final rule.
The Office of Management and Budget has proposed formal federal rules that would centralize grantmaking authority, downgrade peer review, and let political appointees cancel any federal research grant at any time on vague grounds like the “national interest.” The rule would convert OMB guidance into binding procedures, restrict funding for certain culture-war topics, limit international collaborations, and block common research expenses such as publishing and conference travel. Agencies that previously relied on expert staff and peer-review judgments would be required to align programs with administration priorities. Critics warn the changes could politicize funding decisions, undermine scientific quality, and severely damage U.S. research competitiveness.
The OMB is converting a Trump-era executive order into a formal federal rule that would shift US grant decisions from expert peer review to political appointees who could cancel awards at any time citing vague "national interest" reasons. The proposed rules would make peer review secondary, ban grants on certain culture-war topics, restrict international collaborations, and bar spending on publishing and conference travel. This change could upend how federal science funding is distributed, politicize research agendas, hinder collaboration, and expose agencies to legal and operational challenges. Scientists, universities, and research funders are the primary stakeholders, with implications for US competitiveness in technology and innovation.
The Office of Management and Budget has moved to formalize a Trump-era executive order into binding federal rules that would overhaul U.S. grantmaking: peer review would become advisory, political appointees could override expert assessments, and agencies could cancel any grant at any time by citing the vague standard of the “national interest.” The proposal also seeks to ban grants on certain cultural topics, restrict international collaborations, and block funds for publishing and conferences. Key players include the OMB and federal science agencies (e.g., NIH, NSF, DOE). If implemented, the rules could centralize control, politicize funding decisions, and significantly weaken research institutions and international scientific cooperation. Public comment and legal challenges are likely.